Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1997
Reporting Date: May 7, 1997
DuPont reported record first-quarter earnings driven by strong performance in its Petroleum and Fibers segments. The company announced a two-for-one stock split approved by shareholders on April 30, 1997, effective May 15, 1997. The Board also increased the quarterly dividend by 10.5%.
Key Financial Metrics
| Metric ($ Millions) | Q1 1997 | Q1 1996 |
|---|---|---|
| Sales | $11,211 | $10,769 |
| Net Income | $1,020 | $879 |
| Earnings Per Share (Basic) | $1.80 | $1.57 |
| Cash Provided by Operations | $587 | $818 |
| Total Debt (Short + Long Term) | $10,404 | $9,000 (Est. based on Q1 96 data) |
| Cash and Cash Equivalents | $1,478 | $1,066 (Dec 31, 1996) |
| Current Ratio | 1.1 | 1.0 (Dec 31, 1996) |
Note: Total Debt for Q1 1996 is estimated based on the $1.4 billion increase in borrowings reported in Q1 1997 and the Q1 1997 total of $10.3 billion.
Material Changes vs. Prior Period
- Profitability: Net income increased 16% to $1.02 billion. Earnings per share rose 15% to $1.80. Excluding a nonrecurring charge in Q1 1996, EPS growth was 12%.
- Revenue: Sales grew 4% to $11.2 billion. Volume increases were offset by lower selling prices, largely due to a stronger U.S. dollar.
- Cash Flow: Operating cash flow decreased 28% to $587 million. This decline was primarily due to a $1.1 billion increase in net operating assets and liabilities (working capital), compared to a $0.5 billion increase in the prior year.
- Debt: Borrowings increased by $1.4 billion, primarily through commercial paper issuance to finance working capital needs.
Segment Performance and Outlook
Industry Segment Results
- Petroleum: Record earnings of $331 million (up 55%). Driven by higher crude oil ($20.52/bbl) and natural gas prices. Upstream earnings up 41%; downstream earnings up 170%.
- Fibers: Earnings of $233 million (up 30%). Strong demand for Lycra, Dacron, and nylon. Sales up 10% on volume growth.
- Chemicals: Earnings flat at $143 million. Lower white pigment earnings offset by specialty chemical gains.
- Life Sciences: Earnings declined 37% to $141 million due to reduced income allocation from the DuPont Merck joint venture and adverse currency effects in agriculture.
- Polymers: Earnings up 5% to $208 million.
Management Commentary and Risks
- Outlook: Capital expenditures for the year are expected to align with the planned $4.1 billion. Working capital increases in Q1 are typically reversed by year-end.
- Legal Contingencies: Significant litigation remains regarding "Benlate" 50 DF fungicide. Over 700 lawsuits have been filed; approximately 60 remain pending, including personal injury and crop damage claims. The company maintains the product did not cause the alleged damages.
- Environmental: Several environmental matters were settled in Q1 1997 (Ohio, Kentucky, West Virginia, Colorado) with penalties and supplemental projects totaling approximately $1.1 million in fines and $1.1 million in projects.
Investor Verification Checklist
- Stock Split Impact: Verify post-split EPS ($0.90) and share count adjustments for future reporting periods.
- Working Capital Reversal: Monitor Q2-Q4 cash flow statements to confirm the reversal of the $1.1 billion seasonal working capital increase.
- Benlate Litigation: Track the status of the ~60 pending lawsuits and potential changes in accruals for estimated costs.
- Currency Exposure: Assess the impact of the strong dollar on future selling prices, particularly in the Chemicals and Life Sciences segments.
- Debt Levels: Confirm if the $1.4 billion increase in commercial paper is a temporary measure or a structural shift in capital structure.